(EMAILWIRE.COM, December 06, 2017 ) According to the report “Global Liquid Biopsy Market,” published by Market Data Forecast, the global market is projected to reach USD 1.75 billion by 2021, at a CAGR of 24.3% from 2016 to 2021.

This technology of liquid biopsy has enormous diagnostic and treatment implications for oncology and it is believed to transform clinical practice. A liquid biopsy, may capture the entire heterogeneity of the disease. This methodology is advantageous over tissue biopsies as monitoring of tumour genomic can be done by taking serial samples.

Liquid biopsy tests are executed to understand the molecular aspects of cancer across the healthcare and research settings, such as hospitals, physicians, pathological and research laboratories. It is a non-invasive blood test that could provide researchers, physicians, and surgeons with information about the cancer profile of the patient and appropriate therapy to improve the survival rate of the cancer patients. It is a rapid process that usually includes a simple blood draw, extraction of nucleic acids from the blood plasma, and amplification of the molecular targets to permit analysis of the defined biomarkers.

Get a comprehensive overview of the Global Liquid Biopsy Market: http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/

Global Liquid Biopsy Market: Drivers & Restraints
Foremost drivers for the liquid biopsy market include. Liquid biopsies are adopted due to the factors such as tolerability and patient convenience. Tissue biopsies cannot be done for few non-small cell lung cancers and liquid biopsy procedures are replacing tissue diagnosis procedures in such cases. Liquid biopsy research process involves a large amount of money and frequent clinical trials which is acting as a restraint for the market growth.

Get accurate market forecast and analysis on the Global Liquid Biopsy Market. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample

Global Liquid Biopsy Market: Segmentation

By Cancer Type
• Lung Cancer
• Pancreatic Cancer
• Leukemia
• Other Visceral Cancers

By Sample Type
• Blood
• Urine
• Plasma
• Saliva
• Cerebrospinal

By Diagnostic Approach
• Circulating Tumour cells (CTC)
• Circulating Tumour DNA (ctDNA)
• RNA in exosomes
• Extra-Cellular Vesicles

By End Users
• Reference Laboratories
• Hospital/Physician Laboratories
• Academic and Research Centers
• Other End Users

From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/customize-report

Global Liquid Biopsy Market: Overview
CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period. Therapy selection for metastatic cancer and cancer monitoring are key applications of liquid biopsies. Most Liquid biopsy tests are expected to be blood sample based. A high number of tests under development that use Circulating tumor DNA as biomarker for liquid biopsy.

Multiple gene analysis using NGS technology expected to have higher market application for liquid biopsies. A number of market entities are involved in observational & investigative clinical trials for the development of liquid biopsy tests. Furthermore, the growing concern to reduce cancer mortality, and the need to reduce complications associated to conventional biopsies are major factors expected to drive development over the coming years.

Global Liquid Biopsy Market: Region-wise Outlook
Geographically the market is segmented into North America (U.S.A. and Canada), Europe (U.K., Germany, Italy, France, and Spain), Asia-Pacific (India, China, Australia, South Korea and Japan), Latin America (Mexico, Argentina and Brazil), Middle East and Africa. All major action in the field of liquid biopsy is expected to emerge from North America and Europe region over the forecast period. However, increasing funding for private public partnerships in field of cancer research is expected to fuel the Asia-Pacific Market.

Key Questions Answered
• What will be the market growth till 2021 and what will be the resultant market forecast in the year?
• What was the market size from 2016 to 2021?
• What is the current and future Liquid Biopsy Market outlook in worldwide? What trends are affecting the Global market?
• What is the competitive landscape and market share of major players in the Liquid Biopsy space in global?
• What are the key, high growth markets that Liquid Biopsy manufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Liquid Biopsy currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Liquid Biopsy?
• What are the challenges and barriers that have hindered widespread adoption of Liquid Biopsy?

Global Liquid Biopsy Market: Key Players
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.

Reasons to buy Global Liquid Biopsy Market Report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Diagnostics Segment:

Autoimmune Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-auto-immune-diagnostics-market-1190/

Cervical Cancer Diagnostics and Therapeutics Market: http://www.marketdataforecast.com/market-reports/global-cervical-cancer-diagnostics-and-therapeutics-market-829/

Head and Neck Cancer Diagnostics Market: http://www.marketdataforecast.com/market-reports/head-and-neck-cancer-diagnostics-market-49/

Nuclear Medicine Diagnostics: http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com

Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results